DataLibraryResearch is tracking the market dynamics of the crisis in the Pharma & Healthcare industry amid lock-down changes in the supply chain.

Get detailed analysis of the COVID-19 impact on the Custom Antibody Market

Global Custom Antibody Market Opportunities and Forecast 2020-2027

  • DLR2672
  • 21 July, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Custom Antibody Market, By Service (Antibody Development, Antibody Production & Purification, Antibody Fragmentation & Labeling), By Type (Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies, Other Custom Antibodies), By Source (Mice, Rabbits, Other Sources), By Research Area (Oncology, Infectious Diseases, Neurobiology, Stem Cells, Immunology, Cardiovascular Disease, Other Research Areas), By End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations) and opportunities and forecast 2020-2027

Custom Antibody Market Overview

An antibody is a protein that develops in the body as a normal course of the immune response to various types of infections. The global Custom Antibody market is projected to rise at a significant rate in the next few years. The incidences of infectious diseases have been increasing across the world. These rising diseases are boosting the demand for custom antibodies. This key fact majorly contributes to the growth of the global Custom Antibody market.

Moreover, there is also rising demand across the world for protein therapeutics. Production of custom antibodies and related services are key for protein therapeutics. This fact further propelling the growth of the global Custom Antibody market. Currently, custom antibody production, particularly monoclonal antibodies has experienced clinical as well as commercial success. This success is also supporting to fuel the growth of the global Custom Antibody market.

However, the time and expense involved in the production of these antibodies is the key challenge faced by the global Custom Antibody market. Besides this, growing healthcare investments by both government and industry leaders are anticipated to drive the market in the forthcoming years.

Covid-19 Impact on Custom Antibody Market:

In addition, the current Custom Antibody Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Custom Antibody Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Custom Antibody Market Segment Overview

Based on the service, the Antibody Development segment accounted for the largest share in the Custom Antibody market in 2020. The large share of this segment can be attributed to the increasing focus of researchers on high-quality custom antibodies for reproducibility, which can be hindered when using commercially available antibodies. Additionally, by type, the monoclonal antibodies segment has significant growth in the market in 2020. This is because monoclonal antibodies provide high specificity and selectivity compared to other antibodies and are thus the preferred choice in all types of research studies. In addition, by source, the mice segment accounted for the largest share of the market. Mice are the most preferred hosts for research-use antibody production. Compared to other experimental animals, mice offer advantages of lower feeding costs and ease of maintenance & handling due to their small size.

Custom Antibody Market, By Service

· Antibody Development
· Antibody Production & Purification
· Antibody Fragmentation & Labeling

Custom Antibody Market, By Type

· Monoclonal Antibodies
· Polyclonal Antibodies
· Recombinant Antibodies
· Other Custom Antibodies

Custom Antibody Market, By Source

· Mice
· Rabbits
· Other Sources

Custom Antibody Market, By Research Area

· Oncology
· Infectious Diseases
· Neurobiology
· Stem Cells
· Immunology
· Cardiovascular Disease
· Other Research Areas

Custom Antibody Market, By End User

· Pharmaceutical & Biotechnology Companies
· Academic & Research Institutes
· Contract Research Organizations

Custom Antibody Market Regional Overview

Region-wise, North America accounted for the largest share in the custom antibody market. This can be mainly attributed to the increasing investments in the development of structure-based drug designs, growing research in the fields of genomics and proteomics, and the increasing focus on developing antibody-based therapeutics in this region. Similarly, the market of the Asia Pacific is expected to grow at a significant pace. This growth is attributed to the rise of developing countries such as India and China. Such developing countries are largely investing in life science and genomics research.

Custom Antibody Market, By Geography

· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Custom Antibody Market Competitor overview

Some key developments and strategies adopted by manufacturers in Custom Antibody are highlighted below.

· In 2018, industry leader Abcam launched two new custom antibodies in the custom antibody market. These antibodies are called (PBS)-only recombinant antibodies and anti-PD-L1 antibody clone called MKP1A07310. These custom antibodies are developed by Abcam in collaboration with German giants Merck KGaA.

Custom Antibody Market, Key Players

· Innovagen AB
· ProteoGenix
· Agilent Technologies Inc.  
· Bio-Rad Laboratories Inc.
· Abcam Plc
· Thermo Fisher Scientific Inc.
· Merck Group
· Cell Signaling Technology, Inc.
· GenScript
· BioLegend
· Rockland Immunochemicals

Custom Antibody Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1.Introduction

    • 1.1.Research Scope
    • 1.2.Market Segmentation
    • 1.3.Research Methodology
    • 1.4.Definitions and Assumptions

    2.Executive Summary

      3.Market Dynamics

      • 3.1.Market Drivers
      • 3.2.Market Restraints
      • 3.3.Market Opportunities

      4.Key Insights

      • 4.1.Key Emerging Trends – For Major Countries
      • 4.2.Latest Technological Advancement
      • 4.3.Regulatory Landscape
      • 4.4.Industry SWOT Analysis
      • 4.5.Porters Five Forces Analysis

      5.Global Custom Antibody Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1.Key Findings / Summary
      • 5.2.Market Analysis, Insights and Forecast – By Service
        • 5.2.1.Antibody Development
        • 5.2.2.Antibody Production & Purification
        • 5.2.3.Antibody Fragmentation & Labeling
      • 5.3.Market Analysis, Insights and Forecast – By Type
        • 5.3.1.Monoclonal Antibodies
        • 5.3.2.Polyclonal Antibodies
        • 5.3.3.Recombinant Antibodies
        • 5.3.4.Other Custom Antibodies
      • 5.4.Market Analysis, Insights and Forecast – By Source
        • 5.4.1.Mice
        • 5.4.2.Rabbits
        • 5.4.3.Other Sources
      • 5.5.Market Analysis, Insights and Forecast – By Research Area
        • 5.5.1.Oncology
        • 5.5.2.Infectious Diseases
        • 5.5.3.Neurobiology
        • 5.5.4.Stem Cells
        • 5.5.5.Immunology
        • 5.5.6.Cardiovascular Disease
        • 5.5.7.Other Research Areas
      • 5.6.Market Analysis, Insights and Forecast – By End User
        • 5.6.1.Pharmaceutical & Biotechnology Companies
        • 5.6.2.Academic & Research Institutes
        • 5.6.3.Contract Research Organizations
      • 5.7.Market Analysis, Insights and Forecast – By Region
        • 5.7.1.North America
        • 5.7.2.Europe
        • 5.7.3.Asia Pacific
        • 5.7.4.Latin America, Middle East and Africa

      6.North America Custom Antibody Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1.Key Findings / Summary
      • 6.2.Market Analysis, Insights and Forecast – By Service
        • 6.2.1.Antibody Development
        • 6.2.2.Antibody Production & Purification
        • 6.2.3.Antibody Fragmentation & Labeling
      • 6.3.Market Analysis, Insights and Forecast – By Type
        • 6.3.1.Monoclonal Antibodies
        • 6.3.2.Polyclonal Antibodies
        • 6.3.3.Recombinant Antibodies
        • 6.3.4.Other Custom Antibodies
      • 6.4.Market Analysis, Insights and Forecast – By Source
        • 6.4.1.Mice
        • 6.4.2.Rabbits
        • 6.4.3.Other Sources
      • 6.5.Market Analysis, Insights and Forecast – By Research Area
        • 6.5.1.Oncology
        • 6.5.2.Infectious Diseases
        • 6.5.3.Neurobiology
        • 6.5.4.Stem Cells
        • 6.5.5.Immunology
        • 6.5.6.Cardiovascular Disease
        • 6.5.7.Other Research Areas
      • 6.6.Market Analysis, Insights and Forecast – By End User
        • 6.6.1.Pharmaceutical & Biotechnology Companies
        • 6.6.2.Academic & Research Institutes
        • 6.6.3.Contract Research Organizations
      • 6.7.Market Analysis, Insights and Forecast – By Country
        • 6.7.1.U.S.
        • 6.7.2.Canada

      7.Europe Custom Antibody Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Service
        • 7.2.1.Antibody Development
        • 7.2.2.Antibody Production & Purification
        • 7.2.3.Antibody Fragmentation & Labeling
      • 7.3.Market Analysis, Insights and Forecast – By Type
        • 7.3.1.Monoclonal Antibodies
        • 7.3.2.Polyclonal Antibodies
        • 7.3.3.Recombinant Antibodies
        • 7.3.4.Other Custom Antibodies
      • 7.4.Market Analysis, Insights and Forecast – By Source
        • 7.4.1.Mice
        • 7.4.2.Rabbits
        • 7.4.3.Other Sources
      • 7.5.Market Analysis, Insights and Forecast – By Research Area
        • 7.5.1.Oncology
        • 7.5.2.Infectious Diseases
        • 7.5.3.Neurobiology
        • 7.5.4.Stem Cells
        • 7.5.5.Immunology
        • 7.5.6.Cardiovascular Disease
        • 7.5.7.Other Research Areas
      • 7.6.Market Analysis, Insights and Forecast – By End User
        • 7.6.1.Pharmaceutical & Biotechnology Companies
        • 7.6.2.Academic & Research Institutes
        • 7.6.3.Contract Research Organizations
      • 7.7.Market Analysis, Insights and Forecast – By Country
        • 7.7.1. UK
        • 7.7.2.Germany
        • 7.7.3.France
        • 7.7.4.Italy
        • 7.7.5.Spain
        • 7.7.6.Russia
        • 7.7.7.Rest of Europe

      8.Asia Pacific Custom Antibody Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Service
        • 8.2.1.Antibody Development
        • 8.2.2.Antibody Production & Purification
        • 8.2.3.Antibody Fragmentation & Labeling
      • 8.3.Market Analysis, Insights and Forecast – By Type
        • 8.3.1.Monoclonal Antibodies
        • 8.3.2.Polyclonal Antibodies
        • 8.3.3.Recombinant Antibodies
        • 8.3.4.Other Custom Antibodies
      • 8.4.Market Analysis, Insights and Forecast – By Source
        • 8.4.1.Mice
        • 8.4.2.Rabbits
        • 8.4.3.Other Sources
      • 8.5.Market Analysis, Insights and Forecast – By Research Area
        • 8.5.1.Oncology
        • 8.5.2.Infectious Diseases
        • 8.5.3.Neurobiology
        • 8.5.4.Stem Cells
        • 8.5.5.Immunology
        • 8.5.6.Cardiovascular Disease
        • 8.5.7.Other Research Areas
      • 8.6.Market Analysis, Insights and Forecast – By End User
        • 8.6.1.Pharmaceutical & Biotechnology Companies
        • 8.6.2.Academic & Research Institutes
        • 8.6.3.Contract Research Organizations
      • 8.7.Market Analysis, Insights and Forecast – By Country
        • 8.7.1.China
        • 8.7.2.India
        • 8.7.3.Japan
        • 8.7.4.Australia
        • 8.7.5.South East Asia
        • 8.7.6.Rest of Asia Pacific

      9.Latin America, Middle East and Africa Custom Antibody Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1.Key Findings / Summary
      • 9.2.Market Analysis, Insights and Forecast – By Service
        • 9.2.1.Antibody Development
        • 9.2.2.Antibody Production & Purification
        • 9.2.3.Antibody Fragmentation & Labeling
      • 9.3.Market Analysis, Insights and Forecast – By Type
        • 9.3.1.Monoclonal Antibodies
        • 9.3.2.Polyclonal Antibodies
        • 9.3.3.Recombinant Antibodies
        • 9.3.4.Other Custom Antibodies
      • 9.4.Market Analysis, Insights and Forecast – By Source
        • 9.4.1.Mice
        • 9.4.2.Rabbits
        • 9.4.3.Other Sources
      • 9.5.Market Analysis, Insights and Forecast – By Research Area
        • 9.5.1.Oncology
        • 9.5.2.Infectious Diseases
        • 9.5.3.Neurobiology
        • 9.5.4.Stem Cells
        • 9.5.5.Immunology
        • 9.5.6.Cardiovascular Disease
        • 9.5.7.Other Research Areas
      • 9.6.Market Analysis, Insights and Forecast – By End User
        • 9.6.1.Pharmaceutical & Biotechnology Companies
        • 9.6.2.Academic & Research Institutes
        • 9.6.3.Contract Research Organizations
      • 9.7.Market Analysis, Insights and Forecast – By Country
        • 9.7.1.Brazil
        • 9.7.2.Saudi Arabia
        • 9.7.3.UAE
        • 9.7.4.Rest of LAMEA

      10.Competitive Analysis

      • 10.1.Company Market Share Analysis, 2018
      • 10.2.Key Industry Developments
      • 10.3.Company Profile
      • 10.4.Innovagen AB
        • 10.4.1.Business Overview
        • 10.4.2.Segment 1 & Service Offering
        • 10.4.3.Overall Revenue
        • 10.4.4.Geographic Presence
        • 10.4.5.Recent Development
      *Similar details will be provided for the following companies
      • 10.5.ProteoGenix
      • 10.6.Agilent Technologies Inc.
      • 10.7.Bio-Rad Laboratories Inc.
      • 10.8.Abcam Plc
      • 10.9.Thermo Fisher Scientific Inc.
      • 10.10.Merck Group
      • 10.11.Cell Signaling Technology, Inc.
      • 10.12.GenScript
      • 10.13.BioLegend

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934